ClinicalTrials.gg
CompletedNCT05484726Updated Dec 2, 2024Results posted

Maternal Role in Oral Feed Establishment in Preterm Neonates

An interventional study of perioral sensory motor stimulation in Preterm Birth, Tube Feeding and Swallowing Disorder, sponsored by Fatima Memorial Hospital. Completed at 1 site in Pakistan. Open to participants aged 30 Weeks to 34 Weeks, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-02.

Sponsored by Fatima Memorial Hospital · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Mar 2022, registered Jul 2022).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
30 Weeks to 34 Weeks
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 24 studies in Premature Birth with a site in Pakistan — 4 open to participants now, 5 under way, 1 of them phase 3. Premature Birth · Pakistan.

Enrollment
10th of 20
130 · median 123
Started
2022
with 2 others
No phase
15 of 24
1 open now
Registered
10th of 24
by date
Lead sponsor
1 of 24
Fatima Memorial Hospital

Among the 24 studies in Premature Birth with a site in Pakistan, this one is the 10th largest by enrollment of the 20 interventional ones that give a count, is one of 3 that started in 2022, is one of 15 with no phase, and was the 10th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

4 of the 24 studies in Premature Birth with a site in Pakistan are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 30 Weeks to 34 Weeks · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 24 studies in Premature Birth with a site in Pakistan, or all of them as a file.
02

Study summary

Hypothesis

Preterm babies who receive sensory motor stimulation from their mothers as compared to trained nurses will

  1. Start taking oral feed at the same time as compared to control group
  2. Take the same amount of milk at the commencement of oral feeding
  3. Take milk with equal efficiency
  4. Not face more adverse effects
Read the detailed description

Aim To determine the maternal role in sensory-motor stimulation for oral feed establishment in preterm neonates Objective

  1. Determine the effect of sensory-motor stimulation offered by the mother on the onset of oral feeding
  2. Efficiency of mother-mediated stimulation techniques on oral feeding as compared to trained nurses
  3. Study maternal role in the establishment of oral feed Hypothesis Preterm babies who receive sensory motor stimulation from their mothers as compared to trained nurses will
  1. Start taking oral feed at the same time frame as compared to the control group 2. Take the very same amount of milk at the commencement of oral feeding 3. Take milk with equal efficiency 4. There is no extra burden of adverse effects

Data Collection All on going and related trials for this intervention shall be registered in the ClinicalTrials.gov. Study shall be conducted after ethical approval from IRB. All participants shall be enrolled after written informed consent from mothers after approval from attending neonatologist (annexure 2). All relevant maternal and neonatal data shall be collected on a specially designed proforma (annexure 3) with following details

  1. Part 1: Maternal demographic and clinical data (age, parity, educational qualification, residence, previous preterm baby, job status, diabetes, hypertensive disorders, chronic ailment, multifetal gestation
  2. Part 2: Neonatal demographic data (gender, gestation age, birth weight, growth centiles, diagnosis, APGAR score, noninvasive (NIV) and invasive ventilation with duration, caffeine, days taken for establishment of gavage feeding, age, and weight at commencement of intervention, any other complication during study)
  3. Part 3: Neonatal feeding physiological measurements (SpO2, respiratory rate, heart rate before and after feeding, daily weight gain, type of milk offered)
  4. Part 4: Oral feeding skill (OFS) assessment adapted from the model presented by Lau and Smith (p). All parameters shall be recorded twice a day for D1, D2, and D3 separately. It includes

    • Total volume prescribed (ml)
    • Total volume has taken during feeding (ml)
    • Volume has taken during the first 5 min of feeding (ml)
    • Duration of oral feeding (min)
    • Overall transfer (OT %) volume taken/total volume prescribed
    • Proficiency(PRO%) volume taken during the first 5 min/total volume prescribed
    • Rate of transfer (RT) ml/min
    • SSB (Suck Swallow Breaths) coordination
    • Adverse events (cough, fatigue)
    • According to this oral feeding ability can be classified into four levels depending upon the level of maturity in ascending order as follows:

      • Level 1: PRO \< 30% and RT \< 1.5 ml/min
      • Level 2: PRO \< 30% and RT ≥ 1.5 ml/min
      • Level 3: PRO ≥ 30% and RT \< 1.5 ml/min
      • Level 4: PRO ≥ 30% and RT ≥ 1.5 ml/min
03

Conditions studied

  • Preterm Birth
  • Tube Feeding
  • Swallowing Disorder
  • Maternal Care Patterns

Keywords

  • Prematurity
  • sensory-motor stimulation
  • oral feed establishment
  • feeding intervention
04

Who can participate

Ages eligible
30 Weeks to 34 Weeks
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All preterm of gestation age 28 to 34weeks
  • Haemodynamically stable
  • Established full Gavage feed
  • No respiratory distress
  • No need for respiratory support except LFNC
  • Do not receive any kind of analgesics

Exclusion criteria

Exclusion Criteria:

  • Syndromic babies /genetic disorders
  • Haemodynamically unstable babies including IVH (grade III \& IV), hemodynamically significant PDA on treatment, NEC(stage III)
  • Major malformations
  • Cleft lip and palate
  • Anemia requiring blood transfusion
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Care provider)
Enrollment
130 participants (actual)

Study arms

  • Experimental
    Intervention group (Group 1)

    * Maternal involvement shall be in three stages for the intervention group as * Observer status * Performing under supervision * Independent * Study groups for sensory motor stimulation (5 minutes) + pacifier (2 minutes) Intervention group (Group I): by mothers 1. T1: Nurses performing all steps while mother observer status 2. T2: Nurses perform all steps in front of the mother and a pacifier will be offered by the mother 3. D1: Mother performs all steps and oral milk shall be offered by the nurse while the mother observes. 4. D2: Mother performing all steps and offering oral milk while the nurse is supervising 5. D3: Mother performing all steps independently

    Other: perioral sensory motor stimulation

  • Sham comparator
    Control group (Group 2)

    All steps will be the same as the intervention group and shall be performed by staff nurses

    Other: perioral sensory motor stimulation

Interventions

  • Otherperioral sensory motor stimulation

    Step 1 - 6 over 5 minutes 1 With the help of the index finger, on the external surface of the cheek, make a circle starting from the angle of the mouth towards the ear then back 7x each cheek 2 While holding both sides of the cheek with help of the thumb and index finger repeat step 1 7x each cheek 3 Move index finger from one corner to opposite one over both lips separately 7x each lip 4 Gentle massage and compress the gums from center to back of mouth 7x each half of the gum 5 Move the finger from front to back on the hard palate while applying gentle pressure 7x 6 Displace the center of the tongue with gentle pressure 7x 7 Offer pacifier at the end 2 minutes Note: 7x means 7 times

06

What researchers measure

Primary outcomes

  1. Transition Time to Full Oral Feeding

    Time interval between commencement of perioral sensory stimulation on D1 to establishment of full oral feed in both groups. It was done daily till 14th day of perioral sensory motor stimulation. Transition time to full oral feeding was the day at which baby was able to take oral feed of volume of 120-140ml/kg/day.

    Time frame: Expected time of oral feed establishment

  2. Improvement (Change) in Efficiency in Oral Feed Establishment

    According to this efficiency in oral feed establishment in terms of amount and time is determined for the intervention group vs the control group. It can be classified into four levels depending upon the level of maturity in ascending order as follows: * Level 1: PRO \< 30% and RT \< 1.5 ml/min * Level 2: PRO \< 30% and RT ≥ 1.5 ml/min * Level 3: PRO ≥ 30% and RT \< 1.5 ml/min * Level 4: PRO ≥ 30% and RT ≥ 1.5 ml/min For all neonates, efficacy was measured at 11.00 am and 5.00 pm following sensory motor stimulation for both groups till achievement of full oral feed.

    Time frame: For record purpose in this study results, efficacy level was noted as L4 on the following days D1, D2, D3, D5, D7 and D14

  3. •Adverse Outcome Monitoring

    monitor for any adverse events like cough, breath holding, chocking, aspiration, tachycardia, and or bradycardia with 1. stimulation 2. feed Adverse outcome monitoring as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

    Time frame: Adverse events were noted on D1, D2,D3,D5,D7 and D14

  4. •Adverse Events Monitoring

    monitor for any adverse events like cough, breath holding, chocking, aspiration, tachycardia, and or bradycardia with 1. stimulation 2. feed Adverse outcome monitoring as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

    Time frame: Adverse events were noted on D1, D2,D3,D5,D7 and D14

Secondary outcomes

  1. • Total Volume Taken During Each Feeding

    It is the measure of how much feed has been taken orally out of total feed prescribed for each feeding

    Time frame: It was noted on D1, D2, D3, D5, D7 and D14

  2. • Volume Taken During the First 5 Min of Feeding (ml) VT5

    during each feed taken orally by neonate VT5 is the amount of feed was taken by neonate during first 5 minutes

    Time frame: Volume taken during the first 5 min of feeding (ml) VT5 was measured on D1, D2, D3, D5, D7 and D14

  3. •Rate of Transfer (RT) ml/Min

    RT is the time taken by neonate to finish oral feed

    Time frame: RT was measured on D1, D2, D3, D5, D7 and D14

  4. • Overall Transfer (OT Percent) Volume Taken/Total Volume Prescribed

    trend towards oral feed establishment and is measured as overall transfer of milk yo oral out of total amount prescribed

    Time frame: OT was measured on D1, D2, D3, D5, D7 and D14

  5. • Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume Prescribed

    how much amount of milk is taken during first 5 minutes while administering oral feeding

    Time frame: PRO % was measured on D1, D2, D3, D5, D7 and D14

  6. • Neonates Feeding With SSB Coordination

    number of neonates who are feeding well and showing coordinated pattern of suck swallow and breath (SSB)

    Time frame: It was measured on D1, D2, D3, D5, D7 and D14

07

Results

Posted Dec 2, 2024

Participant flow

The study period spans 16 months (March 2022 - July 2023), in the department of Neonatology, Fatima Memorial Hospital, Lahore. All preterm of gestation age 28 to 34 weeks, admitted to NICU during the study period after seeking consent from parents or guardians were enrolled. All neonates having major anomalies incompatible with life, cleft lip and palate, genetic disorders, IVH (grade III \& IV), HsPDA, hemodynamic instability, NEC (stage II \& III) or anemia requiring transfusion were excluded.

Participant flow — Overall Study
MilestoneIntervention Group (Group 1)Control Group (Group 2)
Started6565
Execution of sensory motor stimulation5453
Completed4948
Not completed1617
Withdrew: Protocol violation33
Withdrew: Failure to establish gavage feed by 2 weeks of chronological age42
Withdrew: Hspda requiring antifailure therapy12
Withdrew: Continued need of mechanical ventilation23
Withdrew: Withdrawal by subject23
Withdrew: Ivh (g iii & iv)21
Withdrew: Nec (stage ii & iii)23

Outcome measures

PrimaryTransition Time to Full Oral Feeding

Time interval between commencement of perioral sensory stimulation on D1 to establishment of full oral feed in both groups. It was done daily till 14th day of perioral sensory motor stimulation. Transition time to full oral feeding was the day at which baby was able to take oral feed of volume of 120-140ml/kg/day.

Time frame:
Expected time of oral feed establishment
Reported as:
Median · days
Transition Time to Full Oral Feeding
daysIntervention Group (Group 1)Control Group (Group 2)
Transition Time to Full Oral Feeding10 (7 to 13)9 (7 to 13)
PrimaryImprovement (Change) in Efficiency in Oral Feed Establishment

According to this efficiency in oral feed establishment in terms of amount and time is determined for the intervention group vs the control group. It can be classified into four levels depending upon the level of maturity in ascending order as follows: * Level 1: PRO \< 30% and RT \< 1.5 ml/min * Level 2: PRO \< 30% and RT ≥ 1.5 ml/min * Level 3: PRO ≥ 30% and RT \< 1.5 ml/min * Level 4: PRO ≥ 30% and RT ≥ 1.5 ml/min For all neonates, efficacy was measured at 11.00 am and 5.00 pm following sensory motor stimulation for both groups till achievement of full oral feed.

Time frame:
For record purpose in this study results, efficacy level was noted as L4 on the following days D1, D2, D3, D5, D7 and D14
Reported as:
Count of participants · Participants
Improvement (Change) in Efficiency in Oral Feed Establishment
ParticipantsControl Group (Group 2)Intervention Group (Group 1)
L4 efficacy by D1-300
L4 efficacy by D5912
L4 efficacy by D71516
L4 efficacy by D143635
Primary•Adverse Outcome Monitoring

monitor for any adverse events like cough, breath holding, chocking, aspiration, tachycardia, and or bradycardia with 1. stimulation 2. feed Adverse outcome monitoring as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

Time frame:
Adverse events were noted on D1, D2,D3,D5,D7 and D14
Reported as:
Count of participants · Participants
•Adverse Outcome Monitoring
ParticipantsControl Group (Group 2)Intervention Group (Group 1)
Adverse events D13136
Adverse events D21414
Adverse events D31212
Averse events D502
Adverse events D7 & 1400
Secondary• Total Volume Taken During Each Feeding

It is the measure of how much feed has been taken orally out of total feed prescribed for each feeding

Time frame:
It was noted on D1, D2, D3, D5, D7 and D14
Reported as:
Median · ml
• Total Volume Taken During Each Feeding
mlControl Group (Group 2)Intervention Group (Group 1)
Oral feed volume/feed on D12 (2 to 7)2 (2 to 7)
Oral feed volume/feed on D23 (2 to 7)5 (2 to 9)
Oral feed volume/feed on D34 (3 to 10)7 (3 to 11)
Oral feed volume/feed on D56.5 (5 to 15)8 (5 to 15)
Oral feed volume/feed on D77.5 (7 to 20)9 (7 to 18)
Oral feed volume/feed on D1415.5 (14 to 22)15.5 (13 to 20.5)
Secondary• Volume Taken During the First 5 Min of Feeding (ml) VT5

during each feed taken orally by neonate VT5 is the amount of feed was taken by neonate during first 5 minutes

Time frame:
Volume taken during the first 5 min of feeding (ml) VT5 was measured on D1, D2, D3, D5, D7 and D14
Reported as:
Median · ml
• Volume Taken During the First 5 Min of Feeding (ml) VT5
mlControl Group (Group 2)Intervention Group (Group 1)
VT5 on D12 (1.25 to 4)2 (1 to 4.5)
VT5 on D23 (2 to 5)3 (2 to 6)
VT5 on D33 (2 to 7)3 (2 to 7)
VT5 on D55 (4 to 8)5 (4 to 9)
VT5 on D77 (6 to 10)7 (5.5 to 11)
VT5 on D1410 (9 to 10)10 (9 to 12.5)
Secondary•Rate of Transfer (RT) ml/Min

RT is the time taken by neonate to finish oral feed

Time frame:
RT was measured on D1, D2, D3, D5, D7 and D14
Reported as:
Median · ml/min
•Rate of Transfer (RT) ml/Min
ml/minControl Group (Group 2)Intervention Group (Group 1)
RT on D10.42 (0.28 to 0.70)0.42 (0.24 to 0.85)
RT on D20.71 (0.70 to 1.0)0.70 (0.59 to 1.0)
RT on D30.70 (0.4 to 1.0)0.70 (0.4 to 1.0)
RT on D50.90 (0.50 to 1.2)0.83 (0.50 to 1.45)
RT on D71.0 (0.67 to 1.7)1.0 (0.68 to 1.6)
RT on D141.6 (1.1 to 2.1)1.6 (1.1 to 2.1)
Secondary• Overall Transfer (OT Percent) Volume Taken/Total Volume Prescribed

trend towards oral feed establishment and is measured as overall transfer of milk yo oral out of total amount prescribed

Time frame:
OT was measured on D1, D2, D3, D5, D7 and D14
Reported as:
Median · percentage of volume taken/total volume
• Overall Transfer (OT Percent) Volume Taken/Total Volume Prescribed
percentage of volume taken/total volumeControl Group (Group 2)Intervention Group (Group 1)
OT on D121 (15.3 to 36)21 (15 to 36)
OT on D235.7 (15 to 36)36 (15 to 44)
OT on D343.8 (21 to 50)43.8 (21 to 55.5)
OT on D548 (33 to 65)48 (33 to 65)
OT on D756 (46 to 100)60 (46 to 73.5)
OT on D1495.5 (87.9 to 100)91 (87 to 100)
Secondary• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume Prescribed

how much amount of milk is taken during first 5 minutes while administering oral feeding

Time frame:
PRO % was measured on D1, D2, D3, D5, D7 and D14
Reported as:
Median · percentage of volume taken during the fi
• Proficiency(PRO Percent) Volume Taken During the First 5 Min/Total Volume Prescribed
percentage of volume taken during the fiControl Group (Group 2)Intervention Group (Group 1)
PRO on D116 (9.2 to 21)16 (7.8 to 24)
PRO on D221 (15 to 27)21.6 (15 to 32.5)
PRO on D319.5 (14 to 31)23 (14 to 37)
PRO on D529 (24.5 to 39)30 (25 to 39)
PRO on D739 (32 to 46)39 (33 to 49.5)
PRO on D1455.8 (46 to 56)56 (50 to 60)
Secondary• Neonates Feeding With SSB Coordination

number of neonates who are feeding well and showing coordinated pattern of suck swallow and breath (SSB)

Time frame:
It was measured on D1, D2, D3, D5, D7 and D14
Reported as:
Count of participants · Participants
• Neonates Feeding With SSB Coordination
ParticipantsControl Group (Group 2)Experimental Group (Group 1)
SSB on D12322
SSB on D22733
SSB on D33233
SSB on D53740
SSB on D73639
SSB on D144849
Primary•Adverse Events Monitoring

monitor for any adverse events like cough, breath holding, chocking, aspiration, tachycardia, and or bradycardia with 1. stimulation 2. feed Adverse outcome monitoring as non-life threatening adverse events including cough, tachycardia HR 180-200/min, bradycardia HR120 - 100/min, , tachypnea RR 60 - 70/min while maintaining SpO2 of \>90% at room air

Time frame:
Adverse events were noted on D1, D2,D3,D5,D7 and D14
Reported as:
Count of participants · Participants
•Adverse Events Monitoring
ParticipantsControl Group (Group 2)Intervention Group (Group 1)
Adverse events D13136
Adverse events D21414
Adverse events D31212
Averse events D502
Adverse events D7 & 1400

Adverse events

Collected over For every neonate adverse events were monitored from first day (D1) of perioral sensory - motor stimulation to day of full oral feed establishment expected by Day 14. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention Group (Group 1)0/49 (0%)0/49 (0%)16/49 (32.7%)
Control Group (Group 2)0/48 (0%)0/48 (0%)19/48 (39.6%)
Most frequent other events
Most frequent other events
EventIntervention Group (Group 1)Control Group (Group 2)
Non-life threatening adverse eventsInjury, poisoning and procedural complications16/4919/48

Baseline characteristics

Age, Continuous
Age, Continuous(years)Intervention Group (Group 1)Control Group (Group 2)Total
Median29 (26 to 32)30 (26.5 to 33)29.5 (26.3 to 32.5)
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Intervention Group (Group 1)Control Group (Group 2)Total
Count of participants494897
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Intervention Group (Group 1)Control Group (Group 2)Total
Count of participants——0
Maternal education
Maternal education(Participants)Intervention Group (Group 1)Control Group (Group 2)Total
Uneducated224
Primary111021
Secondary152035
Higher211637
mothers with previous preterm neonates
mothers with previous preterm neonates(Participants)Intervention Group (Group 1)Control Group (Group 2)Total
Count of participants423880
Maternal Job status
Maternal Job status(Participants)Intervention Group (Group 1)Control Group (Group 2)Total
home maker293160
job doing201737
hypertensive disorder of pregnancy
hypertensive disorder of pregnancy(Participants)Intervention Group (Group 1)Control Group (Group 2)Total
Count of participants293261
Gestational diabetes mellitus
Gestational diabetes mellitus(Participants)Intervention Group (Group 1)Control Group (Group 2)Total
Count of participants171734

28 further baseline measures are reported on the registry.

08

Study locations

1 site
  • Rafia Gul
    Lahore, Shadman 54610, Pakistan
09

References and documents

Publications

  • da Rosa Pereira K, Levy DS, Procianoy RS, Silveira RC. Impact of a pre-feeding oral stimulation program on first feed attempt in preterm infants: Double-blind controlled clinical trial. PLoS One. 2020 Sep 9;15(9):e0237915. doi: 10.1371/journal.pone.0237915. eCollection 2020. PubMed 32903261 ↗
  • Murthy SV, Funderburk A, Abraham S, Epstein M, DiPalma J, Aghai ZH. Nasogastric Feeding Tubes May Not Contribute to Gastroesophageal Reflux in Preterm Infants. Am J Perinatol. 2018 Jun;35(7):643-647. doi: 10.1055/s-0037-1608875. Epub 2017 Nov 30. PubMed 29190845 ↗
  • Rogers SP, Hicks PD, Hamzo M, Veit LE, Abrams SA. Continuous feedings of fortified human milk lead to nutrient losses of fat, calcium and phosphorous. Nutrients. 2010 Mar;2(3):230-40. doi: 10.3390/nu2030240. Epub 2010 Feb 26. PubMed 22254018 ↗
  • Viswanathan S, Jadcherla S. Transitioning from gavage to full oral feeds in premature infants: When should we discontinue the nasogastric tube? J Perinatol. 2019 Sep;39(9):1257-1262. doi: 10.1038/s41372-019-0446-2. Epub 2019 Jul 31. PubMed 31366911 ↗
  • Greene Z, O'Donnell CP, Walshe M. Oral stimulation for promoting oral feeding in preterm infants. Cochrane Database Syst Rev. 2016 Sep 20;9(9):CD009720. doi: 10.1002/14651858.CD009720.pub2. PubMed 27644167 ↗
  • 6. Maltese A, Gallai B, Marotta R, Lavano F, Lavano S, Tripi G. The synactive theory of development: the keyword for neurodevelopmental disorders. Acta Medica Mediterranea, 2017, 33: 1257-63
  • Song D, Jegatheesan P, Nafday S, Ahmad KA, Nedrelow J, Wearden M, Nemerofsky S, Pooley S, Thompson D, Vail D, Cornejo T, Cohen Z, Govindaswami B. Patterned frequency-modulated oral stimulation in preterm infants: A multicenter randomized controlled trial. PLoS One. 2019 Feb 28;14(2):e0212675. doi: 10.1371/journal.pone.0212675. eCollection 2019. PubMed 30817764 ↗
  • Bertoncelli N, Cuomo G, Cattani S, Mazzi C, Pugliese M, Coccolini E, Zagni P, Mordini B, Ferrari F. Oral feeding competences of healthy preterm infants: a review. Int J Pediatr. 2012;2012:896257. doi: 10.1155/2012/896257. Epub 2012 May 17. PubMed 22675368 ↗
  • Simpson C, Schanler RJ, Lau C. Early introduction of oral feeding in preterm infants. Pediatrics. 2002 Sep;110(3):517-22. doi: 10.1542/peds.110.3.517. PubMed 12205253 ↗
  • Lau C, Sheena HR, Shulman RJ, Schanler RJ. Oral feeding in low birth weight infants. J Pediatr. 1997 Apr;130(4):561-9. doi: 10.1016/s0022-3476(97)70240-3. PubMed 9108854 ↗
  • Sarin E, Maria A. Acceptability of a family-centered newborn care model among providers and receivers of care in a Public Health Setting: a qualitative study from India. BMC Health Serv Res. 2019 Mar 21;19(1):184. doi: 10.1186/s12913-019-4017-1. PubMed 30898170 ↗
  • 13. Fonseca SA, Silveira AO, Franzoi MAH, Motta E. Family centered-care at the neonatal intensive care unit (NICU): nurses' experiences. Enfermería: Cuidados Humanizados. 2020; 9(2): 170-190
  • Ghomi H, Yadegari F, Soleimani F, Knoll BL, Noroozi M, Mazouri A. The effects of premature infant oral motor intervention (PIOMI) on oral feeding of preterm infants: A randomized clinical trial. Int J Pediatr Otorhinolaryngol. 2019 May;120:202-209. doi: 10.1016/j.ijporl.2019.02.005. Epub 2019 Feb 5. PubMed 30851536 ↗
  • Fucile S, Gisel EG, McFarland DH, Lau C. Oral and non-oral sensorimotor interventions enhance oral feeding performance in preterm infants. Dev Med Child Neurol. 2011 Sep;53(9):829-835. doi: 10.1111/j.1469-8749.2011.04023.x. Epub 2011 Jun 27. PubMed 21707601 ↗
  • Lau C, Smith EO. A novel approach to assess oral feeding skills of preterm infants. Neonatology. 2011;100(1):64-70. doi: 10.1159/000321987. Epub 2011 Jan 5. PubMed 21212698 ↗
  • Majoli M, De Angelis LC, Panella M, Calevo MG, Serveli S, Knoll BL, Ramenghi LA. Parent-Administered Oral Stimulation in Preterm Infants: A Randomized, Controlled, Open-Label Pilot Study. Am J Perinatol. 2023 Jun;40(8):845-850. doi: 10.1055/s-0041-1731452. Epub 2021 Jun 28. PubMed 34182577 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — After approval from the publishing journal once the study has been completed

Supporting information: Study protocol, Statistical analysis plan

Time frame: 1 year after the study's publication for 3 months

Access criteria: on request to corresponding author

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2022 to primary completion in May 2023, 14 months.

Results were first posted in Dec 2024, 1 year 7 months after primary completion.

Of 746 non-industry interventional studies with no phase under Premature Birth, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's 14 months is below that.

Counting every sponsor, half of 764 studies reached it within 24 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2022
First posted
Aug 2, 2022
StartActual
Mar 1, 2022
Primary completionActual
May 1, 2023
CompletionActual
Sep 6, 2023
Results first posted
Dec 2, 2024
Last update
Dec 2, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05484726
Lead sponsor
Fatima Memorial Hospital
Responsible party
Rafia Gul (Assistant Professor, Fatima Memorial Hospital) — Principal investigator
First posted
Aug 2, 2022
Start date
Mar 1, 2022
Primary completion
May 1, 2023
Completion
Sep 6, 2023
Results posted
Dec 2, 2024
Last update
Dec 2, 2024

Study contacts

Rafia Gul, FCPS (Neo)
principal investigator · Fatima Memorial Hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion